相关实验视频
Updated: Jun 4, 2025

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.8K
[具有TP53突变的扩散性大B细胞淋巴瘤的临床特征和预后分析]
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen518116, China.
Zhonghua yi xue za zhi
|December 18, 2024
概括
患有TP53突变扩散大B细胞淋巴瘤 (DLBCL) 的晚期或升高的LDH患者的预后较差. BCL2放大也表明结果更差,但组合治疗可能会改善早期DLBCL预后.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个

